drugset
drugset / Trial / NCT04015375

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

NCT04015375 ↗

Phase 3 Completed 1150 enrolled Torrent Pharmaceuticals Limited Catawba Research · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the therapeutic effect of Dapsone and Placebo gel in the treatment of acne vulgaris.

Timeline

Start
2019-07-11
Primary completion
2020-02-03
Completion
2020-02-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapsone Small molecule 7.5 % Topical

Indications

acne